Recently methods were developed to genetically encode unnatural amino acids and incorporate them efficiently and site-specifically into proteins. These unnatural amino acids have various chemical, physical and biological properties, which allow the functionalisation or generation of proteins with enhanced traits for biochemical analysis, or pharmaceutical and diagnostic purposes. [1] Here orthogonal functional tRNAsynthetase tRNA pairs in an amber suppression system are used, where the tRNA recognises the amber stop codon, such as the pyrrolysyl tRNAsynthetase tRNA CUA pair (PylRS/tRNA CUA ) from methanogenic Archaea. [2] These Archae utilize PylRS/tRNA CUA to incorporate pyrrolysine (Pyl), the 22 nd amino acid, in the active site of enzymes involved in their methane metabolism. [3] Next to Pyl, PylRS also accepts other lysine derivatives as substrates. Using the PylRS/ tRNA CUA from Methanosarcina mazei we in-corporated ε-N-propionyl-, ε-N-butyryl-, and ε-N-crotonyl-lysines into histone H3. [4] These lysine derivatives were recently found as novel histone modifications. [5] The so modified histones could be used to identify proteins recognising these modifications. In addition PylRS was evolved in an iterative saturation mutagenesis screen to utilise lysine derivatives with a norbonene functional head group. This PylRS tripple mutant (Y302G, Y384F, I405R= PylRS-Norb) was shown to be essential for the efficient incorporation of norbonene. [6] The target proteins site-specifically containing the norbonene can be further quantitatively, chemically modified using click-chemistry. ( [6] and unpublished data). In order to shed light onto the substrate specificity of PylRS, we cocrystallised and solved the structures of wildtype enzyme from M. mazei in complex with ε-N-propionyl-, ε-N-butyryl-, ε-N-crotonyl-and alkyl-lysine, ranging from 2.0-2.7Å. Furthermore we present here the co-crystal structure of the PylRS-Norb in complex with the adenylated norbonene amino acid, explaining why these three mutations are essential to enable the enzyme to utilise norbonene efficiently as a substrate. Two of the mutations (Y384F, I405R) are positioned at the active site closing loop, which was shown previously to play a dual role: protection of the adenylated amino-acid in absence of the tRNA and determination of the substrate specificity in class II synthetases. [7, 8] However the third mutation, Y306G, enlarges the active site and is necessary to accommodate the bulky functional norbonene head group, without perturbing the binding pocket. Thus PylRS-Norb can transfer endo-, exo-as well as cyclopropyl norbonene amino acids to its respect tRNA, which are than efficiently incorporated into the polypeptide chains. In summary our data provide penetrating insights into the structural basis for the sitespecific incorporation of unnatural amino acids into proteins by the PylRS/ tRNA CUA system from M. mazei.
